Viveve Medical, Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Viveve Medical, Inc. (VIVE) designs, develops, manufactures, and markets medical devices for non-invasive treatments targeting vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence; its core offering, the Viveve System, comprises a radiofrequency generator, reusable handpiece, treatment tip, cryogen canister, and other consumable components including single-use disposable treatment tips that generate recurring revenue. The company serves physicians such as gynecologists, urologists, plastic surgeons, and dermatologists through direct sales and distributors across the United States, Canada, Asia Pacific, Europe, the Middle East, Latin America, and other international markets. Founded in 2005 and headquartered at 345 Inverness Drive South, Building B, Suite 250, Englewood, Colorado, Viveve Medical operates in the medical devices segment of the healthcare industry with approximately 47 employees. In recent developments, InMode Ltd. acquires Viveve Medical's intellectual property assets, including worldwide patents related to women's wellness and stress urinary incontinence treatments, fortifying InMode's portfolio in radiofrequency-based solutions as of 2023 and 2024. The company faced a bankruptcy filing in late 2023 followed by an asset sale to Lazurite Holdings LLC, marking a significant operational restructuring while its historical focus on cryogen-cooled monopolar radiofrequency technology persists through these transitions. Previously, Viveve obtained CE Mark clearance for its next-generation 2.0 System and consumable tips, enabling sales in over 30 countries beyond the United States, alongside FDA approvals for general surgical applications.
SURMOUNT Advises VIVE Collision on Sale-Leaseback Portfolio Transaction with Four Corners Property Trust
Mynd Immersive, Select Rehabilitation, HTC VIVE, and AT&T Expand Next Generation of Immersive Therapeutics to More Than 150 U.S. Senior Living Communities
Why Is Viveve Medical (VIVE) Stock Down 69% Today?
Viveve Medical, Inc. (VIVE) Q3 2022 Earnings Call Transcript
Viveve to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10, 2022
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2022 Results - Earnings Call Transcript
Viveve to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 11, 2022
Viveve to Participate in H.C. Wainwright Global Investment Conference
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q1 2022 Results - Earnings Call Transcript
Viveve to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 12, 2022
Viveve Medical Inc. (VIVE) CEO Scott Durbin on Q4 2021 Results - Earnings Call Transcript
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q3 2021 Results - Earnings Call Transcript
Viveve to Host Conference Call on November 11, 2021 to Report Third Quarter Financial Results and Provide Corporate Update
Are Biotech Penny Stocks Worth Buying? Check These 3 Out
Viveve to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2021 Results - Earnings Call Transcript
Viveve Reports Second Quarter 2021 Financial Results and Provides Corporate Update
VIVE Stock Price Increases Over 3% Pre-Market: Why It Happened
Viveve Announces Continued Expansion of IP Portfolio with Issuance of Canadian Patent
Viveve to Participate in Ladenburg Thalmann Healthcare Virtual Conference